Eriacta
In brief
- Eriacta is not licensed in the UK; its active ingredient sildenafil is a prescription-only medicine in the UK.
- Eriacta (sildenafil citrate) is used to treat erectile dysfunction; it is a phosphodiesterase type 5 (PDE5) inhibitor that enhances nitric oxide–mediated increases in cyclic GMP, causing smooth muscle relaxation and increased blood flow to the penis.
- The usual dose for adult men under 65 is 50 mg taken as needed (maximum 100 mg once per 24 hours); elderly patients or those with renal/hepatic impairment often start at 25 mg and may be titrated up as tolerated.
- Eriacta is supplied as oral film‑coated tablets (commonly 50 mg and 100 mg, often 4 tablets per blister strip) to be swallowed whole.
- Onset of action is typically 30–60 minutes after dosing, though some users may notice effects sooner (around 15–30 minutes) especially on an empty stomach and with sexual stimulation.
- Duration of action is generally about 4–5 hours, during which the ability to achieve an erection may be improved; individual response varies.
- Do not consume excessive alcohol with Eriacta — alcohol can increase dizziness, reduce erectile response and worsen side effects such as low blood pressure and drowsiness.
- The most common side effect is headache; other frequent effects include flushing, nasal congestion, dyspepsia, dizziness and visual disturbances (blurred vision or colour tinge).
- Would you like to try Eriacta without a prescription?
Basic Eriacta information
- INN (international nonproprietary name): sildenafil (as sildenafil citrate)
- Brand names: Eriacta (Ranbaxy Laboratories; not licensed in the UK).
- ATC code: G04BE03
- Forms and dosages: Film-coated tablets commonly available in 25 mg, 50 mg and 100 mg strengths; Eriacta frequently supplied as 50 mg or 100 mg tablets in 4-per-strip blister packs.
- Manufacturers: Ranbaxy Laboratories
- Registration status in the United Kingdom: Eriacta is not licensed in the UK
- OTC / Rx classification: Prescription-only (Rx); sildenafil 100 mg is a prescription-only medicine (POM) in the UK.
Critical warnings, restrictions and patient protection
Is this medicine safe for everyone and how will the pharmacist protect you?
The active ingredient is sildenafil citrate and it is a prescription-only medicine in the UK, where MHRA and NHS guidance apply.
Absolute contraindications include concurrent use of nitrates or nitric oxide donors, severe cardiovascular disease, known hypersensitivity to sildenafil, and recent stroke or myocardial infarction.
Use with caution or dose reduction is required in renal or hepatic impairment, retinitis pigmentosa, anatomical penile deformities and conditions predisposing to priapism.
ATC classification is G04BE03 (PDE5 inhibitor class) and explains class safety considerations.
Pharmacist triage should screen for nitrates, alpha‑blockers, anticoagulants, cardiac history and priapism risk before supply.
- Absolute contraindications: concurrent nitrates or nitric oxide donors; known hypersensitivity; recent myocardial infarction or stroke; severe hypotension.
- Relative contraindications / caution: severe hepatic or renal impairment; retinitis pigmentosa; predisposition to priapism (sickle cell disease, leukaemia, multiple myeloma); significant cardiac disease.
- Emergency actions checklist:
- If an erection lasts longer than four hours seek immediate emergency care (risk of priapism and permanent damage).
- If sudden loss of vision or sudden hearing loss occurs, stop the medicine and get urgent medical assessment.
- If severe hypotension or chest pain occurs call emergency services and inform clinicians about sildenafil use.
Store and transport at 15–30°C and keep in original packaging, out of reach of children, following storage guidance in the product information.
Report suspected adverse reactions via the MHRA Yellow Card scheme.
High-risk groups
Who needs special caution and how should dosing be adjusted?
| Risk group | Recommended starting dose | Monitoring required |
|---|---|---|
| Elderly (≥65) | 25 mg | Monitor blood pressure, dizziness and drug interactions; titrate carefully |
| Renal or hepatic impairment | 25 mg | Assess liver/renal function and review concomitant meds (CYP3A4 inhibitors) |
| Sickle cell disease, leukaemia, multiple myeloma | Generally avoid unless specialist advised | Specialist review due to priapism risk |
- Priapism: a prolonged erection lasting more than four hours that can cause permanent damage if not treated promptly.
- Hypotension: an abnormally low blood pressure that may cause dizziness, fainting or shock.
- Hepatic/renal impairment: reduced liver or kidney function that alters drug metabolism or excretion and may require dose adjustment.
Start elderly or organ‑impaired patients at a lower dose (25 mg) and titrate using clinical response and tolerability as guidance.
Interaction with activities
Will sildenafil affect driving or safety‑critical work?
Sildenafil can cause dizziness, visual disturbances and syncope and people must assess fitness to perform safety‑critical tasks before driving or operating machinery.
If affected by drowsiness, dizziness or blurred vision do not drive and inform your employer if in a safety‑critical role.
Alcohol may worsen side effects and should be limited around dosing.
For safety‑critical workers (HGV drivers, pilots, maritime staff) follow employer medical guidance and CAA/DVLA/Maritime guidance; consider occupational health referral before use.
- Pre‑use checklist: consult GP or pharmacist; avoid alcohol around dosing; do not mix with nitrates; trial dose when not required to perform safety‑critical tasks to assess effects.
- Symptoms affecting fitness to drive: dizziness; blurred vision; sudden drowsiness; syncope; confusion.
Can I drive after taking it in the United Kingdom?
Short answer: only if you feel fully alert with no dizziness, visual changes or drowsiness.
If affected, do not drive and seek medical advice.
Safety‑critical workers must follow employer, CAA, DVLA and maritime guidance and document advice in occupational health records.
Report any driving‑related adverse events to the MHRA Yellow Card scheme.
Usage basics: INN, brand names and legal classification
What is Eriacta and how is it classified?
The INN is sildenafil citrate and Eriacta is a Ranbaxy Laboratories generic sildenafil product that is not licensed in the UK.
- Brands and strengths: Eriacta (50 mg, 100 mg common); licensed sildenafil products in the UK come in 25 mg, 50 mg and 100 mg strengths.
- Legal classification: sildenafil is a prescription‑only medicine (POM) in the UK.
- Note: one licensed sildenafil 50 mg product has pharmacy‑only (P) status in the UK; this does not apply to Eriacta.
| Brand | Typical form | Typical strengths |
|---|---|---|
| Eriacta | Film-coated tablet, blister | 50 mg, 100 mg (common) |
| Licensed sildenafil | Film-coated tablet | 25 mg, 50 mg, 100 mg |
| Other generics | Tablet | Varied dosages |
Dosing guide
How should sildenafil be taken for erectile dysfunction?
Standard starting dose for adult men under 65 is 50 mg taken 30–60 minutes before sexual activity with a maximum of 100 mg once per 24 hours.
Elderly patients and those with renal or hepatic impairment should start at 25 mg and titrate as tolerated.
Sildenafil for ED is typically used on‑demand rather than daily; daily regimens should only be used under clinician supervision.
Missed dose is not applicable for on‑demand use; overdose requires urgent medical attention for risks including severe hypotension and priapism.
- Dosing checklist: start 50 mg (adult <65); start 25 mg (elderly or organ impairment); maximum 100 mg/24 hrs; take 30–60 minutes before activity.
| Patient group | Starting dose |
|---|---|
| Adult men <65 | 50 mg |
| Elderly (65+) | 25 mg |
| Renal/hepatic impairment | 25 mg (adjust as tolerated) |
What if I miss a dose?
For on‑demand sildenafil there is no scheduled daily dosing so a “missed dose” does not apply.
If you took less than intended before activity do not take an extra dose within 24 hours.
For any prescribed daily regimens follow your prescriber’s instructions and consult the GP or pharmacist if unsure.
Interaction chart: food, drink and medicines
Which foods, drinks and medicines interact with sildenafil and what should you do?
| Drug/food class | Interaction | Action |
|---|---|---|
| Nitrates / nitric oxide donors | Severe hypotension | Avoid combination (absolute contraindication) |
| Alpha‑blockers | Additive hypotensive effect | Start at lower dose, monitor BP; avoid rapid standing |
| CYP3A4 inhibitors (some antifungals, macrolides, protease inhibitors) | Increased sildenafil levels, increased side effects | Reduce dose or choose alternative |
| Alcohol / heavy meals | Delayed onset and increased dizziness | Limit alcohol; avoid heavy fatty meals at dosing |
- Immediate actions if severe hypotension occurs:
- Lie flat and raise legs.
- Call emergency services if not improving.
- Inform attending clinicians about recent sildenafil use.
Always check the BNF or electronic medicines compendium for up‑to‑date interaction advice and report suspected reactions to MHRA Yellow Card.
Legal status and availability in the UK
In our online pharmacy, Eriacta is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Mechanism of action and pharmacology
How does sildenafil work in simple clinical terms and what does the pharmacology mean for safety?
Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor that enhances nitric oxide–mediated vasodilation in the corpus cavernosum by inhibiting PDE5 and increasing cyclic GMP to facilitate erection with sexual stimulation.
Onset is typically 30–60 minutes and duration varies up to several hours depending on dose and person.
Metabolism is primarily hepatic via CYP3A4 and renal excretion of metabolites explains interaction risk with CYP3A inhibitors and the need for dose adjustment in organ impairment.
- PDE5: enzyme that breaks down cGMP in penile tissue.
- cGMP: cyclic guanosine monophosphate, mediator of smooth muscle relaxation.
- Tmax: time to peak plasma concentration, commonly around 30–120 minutes depending on formulation.
- CYP3A4: liver enzyme responsible for sildenafil metabolism; inhibitors increase sildenafil levels.
| Mechanism | Effect | Clinical implication |
|---|---|---|
| PDE5 inhibition | Increased cGMP | Improved erectile response with sexual stimulation |
| CYP3A4 metabolism | Variable plasma levels with inhibitors/inducers | Adjust dose or avoid combinations |
Indications and off‑label uses
What is sildenafil licensed for and what are the common off‑label ideas?
Licensed indication is erectile dysfunction, and other sildenafil formulations are licensed for pulmonary arterial hypertension under different brand names (e.g., Revatio for PAH).
Eriacta is marketed as a generic sildenafil for ED and relies on the same active ingredient as branded products, but it is not licensed in the UK.
- Licensed uses: Erectile dysfunction; other brands used for PAH under specialist supervision.
- Off‑label uses: occasional trials for female sexual dysfunction or adjuncts in premature ejaculation, but evidence is limited and not routinely recommended without specialist oversight.
- Pros/cons checklist for off‑label use:
- Pros: potential benefit in selected cases under specialist care.
- Cons: limited evidence, potential for harm and legal/policy issues; obtain informed consent and document rationale if prescribed off‑label.
Alternatives matrix
What are suitable alternatives when sildenafil is unsuitable or ineffective?
| Drug / device | Active ingredient | Onset | Duration | Typical dosing | Pros | Cons |
|---|---|---|---|---|---|---|
| Viagra | Sildenafil | 30–60 min | Several hours | 25–100 mg | Well‑studied, familiar | Originator brand |
| Tadalafil tablets | Tadalafil | 30–60 min | Up to 36 hrs | 10–20 mg or daily low dose | Longer duration, daily option | Daily dosing considerations, interactions |
| Levitra | Vardenafil | Often faster | Several hours | 5–20 mg | Faster onset for some | Variable tolerability |
| Intracavernosal alprostadil | Alprostadil | Minutes | Short | Injection per clinic protocol | Effective when PDE5 inhibitors fail | Invasive, training required |
| Vitaros | Alprostadil topical | Quick | Short | Topical application | Non‑injectable alternative | Local irritation |
| Vacuum device | Mechanical | Immediate | Up to activity | Device use | No systemic effects | Practical limitations, device handling |
- Choosing therapy checklist: consider comorbidities, interactions (nitrates, alpha‑blockers), patient preference, renal/hepatic function and occupational risks.
- Refer to urology or sexual health services if first‑line therapy fails or if there is penile deformity or priapism history.
Common questions
What are the most frequent questions patients ask in the UK and short answers.
- Will sildenafil work first time? — Clinical response varies; try several attempts while addressing technique and underlying conditions before judging efficacy.
- Is it safe with heart meds? — Not with nitrates; always consult GP or cardiologist if on cardiac medications before taking sildenafil.
- Can partners take it? — Sildenafil is not indicated for women with ED in standard practice; partner support and sexual counselling are recommended.
- Where to report side effects? — Report via the MHRA Yellow Card scheme and notify your prescriber or pharmacist.
Urgent care checklist: seek emergency help for priapism (>4 hours), sudden vision or hearing loss, chest pain or collapse.
Registration and regulation
Who regulates sildenafil products and how do pharmacists verify authenticity?
The MHRA is responsible for market authorisation, safety monitoring and recall actions in the UK.
Eriacta is not licensed in the UK; licensed sildenafil products are listed by the MHRA and in the electronic medicines compendium.
- Steps to verify product authenticity:
- Check packaging and patient information leaflet (PIL) for manufacturer details.
- Confirm marketing authorisation and manufacturer (Ranbaxy Laboratories for Eriacta according to product data).
Report adverse events via the MHRA Yellow Card scheme and follow local formulary or NHS guidance for prescribing and supply.
Storage and handling for United Kingdom households
How should patients keep sildenafil at home and when travelling?
Store at 15–30°C, protected from moisture, keep in original blister to preserve expiry and lot information and keep out of reach of children.
UK homes can be damp so avoid bathroom storage; choose a cool, dry cupboard instead.
For travel, carry medication in original packaging with prescription or a clinician’s letter when crossing borders and check import rules for destination countries.
Dispose of unused medication at pharmacy take‑back services—do not flush down the toilet.
| Storage condition | Recommendation |
|---|---|
| Temperature | 15–30°C |
| Moisture | Keep in original blister; avoid bathrooms |
| Sunlight / Heat | Avoid direct sunlight and high heat sources |
- Household checklist: original packaging, cool dry place, locked away from children, take‑back unused supplies to pharmacy.
- Pharmacy note: maintain batch recall readiness and storage logs for stock control.
Guidelines for proper use and pharmacist counselling
What should pharmacists cover during counselling and what handouts help patients?
Confirm indication and review medical history focusing on cardiac disease, nitrates, priapism risk and any interacting medicines.
Advise dosing timing (30–60 minutes pre‑activity), dose limits (max 100 mg per 24 hours), and common side effects with practical management tips.
- Counselling checklist:
- Confirm patient identity and indication.
- Review current medicines, allergies and comorbidities.
- Explain dosing, onset, duration and what to do for side effects.
- Highlight emergency symptoms requiring urgent care (priapism, sudden vision/hearing loss, chest pain).
- Patient handout points:
- What to expect after taking the tablet and how long it may work.
- When to stop treatment and seek urgent help.
- How to report side effects via MHRA Yellow Card.
Verify authenticity of Eriacta by checking manufacturer Ranbaxy, blister packaging and correct strengths (50 mg and 100 mg are commonly supplied).
Provide non‑judgemental, private counselling and document advice in dispensing notes or NHS EPS records where appropriate.
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | Greater Manchester | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Liverpool | Merseyside | 9–21 days |
| Bristol | South West England | 9–21 days |
| Newcastle Upon Tyne | North East England | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Nottingham | Nottinghamshire | 9–21 days |
| Brighton | East Sussex | 9–21 days |